GeneHealth - Your precision medicine

Familial Atrioventricular Septal Defect

Disease Details

Family Health Simplified

Buy Membership

Description: Familial atrioventricular septal defect is a congenital heart defect characterized by malformations of the atrial and ventricular septa, as well as the atrioventricular valves, often inherited within families.
Type: Familial atrioventricular septal defect (AVSD) is a congenital heart defect where there is a malformation of the atrioventricular septum, leading to abnormal communication between the heart's chambers. The type of genetic transmission for familial AVSD is typically autosomal dominant. This means that a mutation in just one copy of the associated gene inherited from one parent can increase the risk of developing the condition.
Signs And Symptoms: Familial atrioventricular septal defect (AVSD) is a congenital heart condition where there's a defect in the atrioventricular septum, the part of the heart that separates the atria from the ventricles. Here are the primary signs and symptoms associated with AVSD:

1. Difficulty breathing or rapid breathing
2. Poor feeding or failure to thrive (infants)
3. Fatigue or easily tiring during physical activity
4. Cyanosis (bluish tint to the skin, lips, and fingernails)
5. Frequent respiratory infections
6. A heart murmur detected during a physical examination
7. Swelling of the legs, abdomen, or areas around the eyes (edema)
8. Arrhythmias (irregular heartbeats)
9. Poor weight gain

These symptoms can vary based on the severity of the defect and the presence of any associated heart abnormalities.
Prognosis: Familial atrioventricular septal defect (AVSD) is a congenital heart defect affecting the valves and walls between the heart's chambers. The prognosis largely depends on the severity and associated cardiac anomalies.

Mild cases may have a favorable prognosis post-surgery, allowing normal life expectancy with regular follow-up. Severe cases, especially those with additional complications, can have a more guarded prognosis, requiring ongoing medical intervention and possibly leading to heart failure or other complications.

Prompt diagnosis and appropriate treatment significantly improve outcomes.
Onset: Familial atrioventricular septal defect typically presents at birth or during early infancy. It's a congenital heart defect that affects the structure of the heart.
Prevalence: The prevalence of familial atrioventricular septal defect (AVSD) is relatively rare, with such congenital heart defects occurring in approximately 0.19 per 1,000 live births. Familial cases indicate a genetic predisposition, but specific prevalence rates for familial AVSD are not well-documented.
Epidemiology: Familial atrioventricular septal defect (AVSD) is a congenital heart defect characterized by abnormalities in the atrial and ventricular septa as well as the atrioventricular valves. In terms of epidemiology:

1. **Prevalence:** AVSD occurs in approximately 4-5 per 10,000 live births. It accounts for about 4-5% of all congenital heart defects.
2. **Genetic Factors:** Familial cases are less common and often associated with genetic syndromes such as Down syndrome. The recurrence risk in families can be influenced by genetic factors, indicating a hereditary component.
3. **Demographics:** The condition affects both males and females, but no significant gender predilection has been identified. It occurs across all ethnic groups.

Note: "nan" is not a recognized term in the context of this question. If it refers to a different aspect or data, please provide more context.
Intractability: Familial atrioventricular septal defect (AVSD) is a congenital heart defect that can vary in severity. The intractability of this condition depends on the specific manifestations and severity of the defect. While some cases can be managed effectively through surgical intervention and ongoing medical care, more severe cases may present significant challenges and complications that are harder to manage. Overall, with advances in surgical techniques and medical treatments, many affected individuals can achieve improved outcomes, although long-term follow-up and care are often necessary.
Disease Severity: Familial atrioventricular septal defect (AVSD) is a congenital heart defect that can vary significantly in severity. The severity depends on the size of the defect, the presence of associated cardiac abnormalities, and the overall impact on heart function. Mild cases may be asymptomatic or cause only minor symptoms, while severe cases can lead to significant heart failure, pulmonary hypertension, and other complications requiring surgical intervention. The term "nan" is not applicable in this context.
Pathophysiology: Familial atrioventricular septal defect (AVSD) involves improper development of the heart's structures separating the atria and ventricles, leading to a hole between these chambers and issues with the valves that control blood flow between them. This defect allows oxygen-rich and oxygen-poor blood to mix, which can compromise the heart's efficiency and lead to heart failure, pulmonary hypertension, and arrhythmias. Familial forms suggest a genetic predisposition, often linked to mutations in specific genes that regulate cardiac development and structure.
Carrier Status: Familial atrioventricular septal defect (AVSD) is a congenital heart defect often associated with genetic syndromes such as Down syndrome but can also occur as a familial condition. Carrier status is not typically a relevant concept for AVSD, as it is not usually inherited in a simple Mendelian pattern like autosomal recessive or autosomal dominant traits where carrier status would apply. Instead, its occurrence can be influenced by a combination of genetic and environmental factors. Genetic counseling and testing can provide more specific information for affected families.
Mechanism: Familial atrioventricular septal defect (AVSD) is a congenital heart defect characterized by deficiencies in the atrioventricular septum, leading to abnormalities in the mitral and tricuspid valves.

**Mechanism:**
The defect arises when the endocardial cushions, which contribute to the formation of the atrioventricular septum, mitral valve, and tricuspid valve, fail to fuse properly during cardiac development. This results in a spectrum of malformations that can include a single atrioventricular valve, holes between the chambers of the heart, and improper valve function.

**Molecular mechanisms:**
Several genetic factors have been implicated in the development of AVSD. Mutations in genes such as NKX2-5, GATA4, and CRELD1 have been associated with the defect. These genes are critical for the regulation of cardiac development and function:
- **NKX2-5**: A transcription factor essential for early heart development and the formation of structural components of the heart.
- **GATA4**: Another transcription factor central to the development of the heart and the regulation of other genes involved in cardiac development.
- **CRELD1**: A molecule involved in cell adhesion processes that are crucial for endocardial cushion formation.

Mutations in these genes can disrupt the signaling pathways and transcriptional networks necessary for the formation and proper fusion of the endocardial cushions, leading to the development of AVSD. The inheritance pattern is often autosomal dominant, but penetrance and expressivity can vary, indicating that other genetic, epigenetic, or environmental factors may also contribute to the disease manifestation.
Treatment: Familial atrioventricular septal defect (AVSD) is primarily treated through surgical intervention to repair the septal defects. The specific procedure depends on the severity and the exact nature of the defect. Typically, the surgery involves closing the holes in the septum with patches and reconstructing the atrioventricular valves if necessary. Post-operative care includes regular follow-ups with a cardiologist, medications to manage symptoms, and potentially further interventions if complications arise. Early diagnosis and timely surgery are crucial for optimal outcomes.
Compassionate Use Treatment: Familial atrioventricular septal defect (AVSD) typically requires surgical intervention to correct the structural heart abnormalities. Compassionate use treatments and off-label or experimental treatments are not standard for this congenital condition, but research is ongoing in related areas. Compassionate use may involve investigational medical products for severe cases where standard treatment options are exhausted. Off-label use of medications might be considered to manage associated symptoms or complications, though this is less common. Experimental treatments, such as gene therapy, are being investigated but are not yet available as a standard therapeutic approach. Always consult a healthcare professional for the most current and tailored medical advice.
Lifestyle Recommendations: For individuals with Familial Atrioventricular Septal Defect (AVSD), lifestyle recommendations typically include:

1. **Regular Medical Follow-Up:** Consistent monitoring by a cardiologist to manage the condition and prevent complications.
2. **Medications:** Adherence to any prescribed medications for symptoms or related conditions.
3. **Healthy Diet:** A balanced diet low in sodium and saturated fats to promote heart health.
4. **Physical Activity:** Engage in moderate exercise, as recommended by a healthcare professional, while avoiding strenuous activities that could strain the heart.
5. **Avoid Smoking and Alcohol:** Refrain from smoking and limit alcohol consumption to reduce cardiovascular risk.
6. **Infection Prevention:** Ensure vaccinations are up-to-date and practice good hygiene to avoid infections, particularly endocarditis.
7. **Stress Management:** Employ effective stress-relief techniques such as mindfulness, yoga, or other relaxation methods.
8. **Monitoring Symptoms:** Be vigilant about new or worsening symptoms and seek prompt medical attention when necessary.
9. **Education and Support:** Join support groups or educational programs to better understand and cope with the condition.

Always consult with a healthcare provider for personalized advice tailored to the individual’s specific condition and needs.
Medication: There is no specific medication to treat familial atrioventricular septal defect (AVSD). Management typically involves surgical intervention to correct the structural heart defect. Medications may be used to manage symptoms or complications, such as diuretics to reduce fluid overload, ACE inhibitors to manage heart failure, or beta-blockers to control arrhythmias. The treatment plan should be tailored to the individual patient’s condition and done under the guidance of a cardiologist.
Repurposable Drugs: There are no well-documented repurposable drugs specifically for familial atrioventricular septal defect (AVSD). Treatment typically involves surgical correction to address the structural heart defect. Management of symptoms and associated conditions might include medications like diuretics, ACE inhibitors, or beta-blockers, but these are not specific to AVSD itself.
Metabolites: For Familial Atrioventricular Septal Defect (AVSD), specific information on metabolites directly associated with this congenital heart defect is not well-documented. AVSD is generally more related to genetic and developmental factors rather than specific metabolic pathways. Research into metabolites directly influencing or indicative of AVSD may still be in preliminary stages or not yet well-established in clinical practice. Diagnosis and management primarily focus on imaging, genetic testing, and surgical intervention rather than metabolic profiling.
Nutraceuticals: For familial atrioventricular septal defect (AVSD), there is currently no evidence to suggest that nutraceuticals provide any benefit in preventing or treating this congenital heart condition. Familial AVSD typically requires medical surveillance and often surgical intervention to correct the heart defect. Always consult with a healthcare professional for guidance tailored to individual health needs.
Peptides: Familial atrioventricular septal defect (AVSD) is a genetic condition where there is an abnormal development of the heart's atrioventricular septum, resulting in a defect that involves both the atrial and ventricular septa as well as the AV valves. "Peptides" in this context generally refer to short chains of amino acids that play various roles in biological processes, including cell signaling and structural functions. However, specific therapeutic peptides used in AVSD management are not currently established or widely recognized. Detailed peptide involvement in familial AVSD pathogenesis might be an area of ongoing research.